Does GLP-1 Help With Weight Loss? Science Behind It

Last reviewed: June 5, 2026

Last updated: June 5, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Glucagon-like peptide-1 (GLP-1) agonists represent one of the most significant advances in weight management medicine, with landmark studies showing weight loss ranging from 15% to 22% of body weight over 68 weeks. These medications work by signaling your brain's hunger control centers and slowing digestive processes, creating a dual effect that makes sustainable weight loss more achievable. PlexusDx specializes in precision GLP-1 therapy tailored to your genetic profile and metabolic needs.

How GLP-1 Agonists Work for Weight Loss

GLP-1 is a natural hormone your gut produces when you eat, signaling fullness and reducing appetite. GLP-1 agonist medications amplify this signal, making your brain register satisfaction with smaller portions and less frequent eating urges. The medication also slows gastric emptying—the rate at which food moves through your stomach—which extends the feeling of fullness and stabilizes blood sugar levels throughout the day.

Beyond appetite suppression, GLP-1 agonists influence metabolic pathways that affect how your body stores and uses energy. Research shows these medications can increase insulin sensitivity, reduce cravings for high-calorie foods, and decrease the reward signals your brain receives from eating. This multi-mechanism approach addresses weight loss from several biological angles simultaneously, which explains why outcomes often exceed those of diet and exercise alone.

Clinical Evidence Supporting GLP-1 for Weight Management

The STEP trials, conducted between 2019 and 2021, provided robust evidence for semaglutide's weight loss effectiveness. Participants receiving semaglutide achieved an average weight loss of 14.9% of their starting body weight over 68 weeks, compared to 2.4% in the placebo group. These results represent a clinically meaningful difference, with many participants maintaining weight loss during extended follow-up periods.

Tirzepatide, a dual GLP-1 and GIP receptor agonist, demonstrated even more pronounced results in the SURMOUNT trials, with some participants achieving 22% weight loss. The consistency of these findings across diverse populations—including people with type 2 diabetes and those without—indicates that GLP-1 therapy produces measurable, sustained outcomes. PlexusDx utilizes both semaglutide and tirzepatide options to match your individual response profile and treatment goals.

Genetic Factors That Influence Your GLP-1 Response

Your genetic makeup significantly influences how effectively you'll respond to GLP-1 therapy. Key genetic variants in the GLP1R gene (rs6923761), GIPR gene (rs1800437), and FTO gene (rs9939609) affect receptor sensitivity, hunger hormone signaling, and fat metabolism. Some individuals carry genetic variations that enhance their response to GLP-1 agonists, while others may require dose adjustments or medication combinations to achieve optimal results.

PlexusDx's Precision Peptide Genetic Test analyzes 14 metabolic pathways and 49 peptide-related genes to map your personalized response profile. This test, available as a $99 add-on after your first month of treatment, identifies which medication and dose strategy aligns with your genetic predispositions. Understanding your genetic landscape eliminates guesswork and enables your healthcare provider to prescribe with confidence, maximizing both efficacy and safety.

PlexusDx GLP-1 Treatment Options and Accessibility

PlexusDx offers compounded semaglutide injections starting at $149 per month through licensed 503A compounding pharmacies, with no insurance requirement and HSA/FSA eligibility. The company also provides oral semaglutide, compounded tirzepatide injections, oral tirzepatide, and combination therapies—each priced at consistent monthly rates. Your dose may need to go up as your body adjusts, but your price won't, ensuring transparent, predictable costs throughout your treatment journey.

All PlexusDx medications are sourced from licensed 503A compounding pharmacies and shipped to all 50 states with no membership fees or hidden charges. A Precision Peptide Genetic Test can be added after your first month to refine your treatment protocol based on your unique genetic insights. This combination of accessibility, transparency, and personalization makes PlexusDx an evidence-based option for individuals seeking precision GLP-1 therapy.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How quickly will I see weight loss results with GLP-1 therapy?

Most patients begin noticing appetite reduction within 1-2 weeks of starting GLP-1 therapy, with measurable weight loss typically appearing within 4-8 weeks. However, individual timelines vary based on genetics, starting weight, diet, and exercise.

Is the weight loss from GLP-1 permanent?

Clinical data shows that patients who maintain GLP-1 therapy sustain their weight loss long-term, with most regaining weight only if the medication is discontinued. Studies extending beyond 2 years demonstrate stable or continued weight reduction in consistent users.

What is the cost difference between PlexusDx semaglutide and tirzepatide?

PlexusDx compounded semaglutide injection starts at $149 per month, while compounded tirzepatide injection starts at $249 per month. Both medications are priced flat regardless of dose level, so your price remains consistent as your dose adjusts upward if needed.

Are there side effects I should know about with GLP-1 agonists?

Common side effects include nausea, vomiting, and gastrointestinal discomfort, particularly during dose increases—most of which diminish within 1-2 weeks as your body adapts. Severe pancreatitis and thyroid complications are rare but require medical monitoring.

How does the PlexusDx Precision Peptide Genetic Test help personalize my treatment?

The $99 test maps 150+ genetic insights across 14 metabolic pathways, identifying your unique response patterns to GLP-1 and GIP signaling, fat metabolism, and hunger regulation. Key variants in GLP1R, GIPR, FTO, and MC4R genes reveal whether you'll respond optimally to semaglutide, tirzepatide, or combination therapy.

Does GLP-1 Help With Weight Loss? Exploring the Science Behind GLP-1 Agonists